BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11516262)

  • 1. Captopril and its time of administration in myocardial ischaemic-reperfusion injury.
    Maulik SK; Kumari R; Maulik M; Manchanda SC; Gupta SK
    Pharmacol Res; 2001 Aug; 44(2):123-8. PubMed ID: 11516262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pre- and posttreatment of losartan in feline model of myocardial ischemic-reperfusion injury.
    Kumari R; Manchanda SC; Maulik SK
    Methods Find Exp Clin Pharmacol; 2004; 26(1):39-45. PubMed ID: 14988740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium.
    Cargnoni A; Boraso A; Scotti C; Ghirardelli N; Benigno M; Bernocchi P; Pedersini P; Ferrari R
    J Mol Cell Cardiol; 1994 Jan; 26(1):69-86. PubMed ID: 8196071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of bradykinin antagonist Hoe-140 during in vivo myocardial ischemic-reperfusion injury in the cat.
    Kumari R; Maulik M; Manchanda SC; Maulik SK
    Regul Pept; 2003 Oct; 115(3):211-8. PubMed ID: 14556963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prostaglandin synthesis stimulation in the protective effect of captopril on ischaemia-reperfusion arrhythmias in rats in vivo.
    Birincioglu M; Olmez E; Aksoy T; Acet A
    Pharmacol Res; 1997 Oct; 36(4):299-304. PubMed ID: 9425619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function.
    Ojha S; Golechha M; Kumari S; Bhatia J; Arya DS
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):219-27. PubMed ID: 21975080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats.
    Rajak S; Banerjee SK; Sood S; Dinda AK; Gupta YK; Gupta SK; Maulik SK
    Phytother Res; 2004 Jan; 18(1):54-60. PubMed ID: 14750202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
    Parlakpinar H; Ozer MK; Acet A
    Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
    Anderson B; Khaper N; Dhalla AK; Singal PK
    Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection by Inula racemosa Hook in experimental model of myocardial ischemic reperfusion injury.
    Ojha S; Nandave M; Kumaria S; Arya DS
    Indian J Exp Biol; 2010 Sep; 48(9):918-24. PubMed ID: 21506500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart.
    Traquandi C; Riva E
    Pharmacol Res; 1998 Jan; 37(1):57-65. PubMed ID: 9503481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
    Ozer MK; Sahna E; Birincioglu M; Acet A
    Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of captopril against ischaemia-reperfusion injury in isolated guinea pig hearts.
    Doğan R; Sarigül A; Isbir S; Farsak B; Tuncer M; Kilinç K; Demircin M
    Scand J Clin Lab Invest; 1998 Apr; 58(2):119-26. PubMed ID: 9587163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
    Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
    J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats.
    Krishan P; Sharma A; Singh M
    Pharmacol Res; 1998 Jan; 37(1):23-9. PubMed ID: 9503476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
    Xu D; Zhang S; Foster DJ; Wang J
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury.
    Karthikeyan K; Bai BR; Gauthaman K; Sathish KS; Devaraj SN
    Life Sci; 2003 Oct; 73(21):2727-39. PubMed ID: 13679240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury.
    Arya DS; Bansal P; Ojha SK; Nandave M; Mohanty I; Gupta SK
    Life Sci; 2006 May; 79(1):38-44. PubMed ID: 16457854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.